Skip to content

Functional pulmonary magnetic resonance imaging for the efficacy assessment of balloon pulmonary angioplasty

Functional pulmonary magnetic resonance imaging for the efficacy assessment of balloon pulmonary angioplasty

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077789
Enrollment
Unknown
Registered
2023-11-20
Start date
2023-11-27
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic thromboembolic pulmonary hypertension

Interventions

Patients with chronic thromboembolic pulmonary hypertension:N/A

Sponsors

Beijing Chaoyang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Aged over 20 years old with a stable clinical condition; (2) Diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH) by radionuclide V/Q imaging and right heart catheterization (RHC); (3) Unable to perform intrapulmonary artery Membrane stripping (PEA) or postoperative residual pulmonary hypertension (PH), in line with balloon pulmonary angioplasty (BPA) treatment indications; (4) Expected survival time greater than 12 months.

Exclusion criteria

Exclusion criteria: (1) Refusal to sign the informed consent form; (2) MRI contraindications (implantation of pacemaker/defibrillator, claustrophobia or any clinical condition that prohibits a long-term MRI examination).

Design outcomes

Primary

MeasureTime frame
perfusion defect percent;Ventilation defect percent;V/Q match;

Secondary

MeasureTime frame
Mean pulmonary artery pressure;Pulmonary Vascular Resistance;

Countries

China

Contacts

Public ContactQi Yang

Beijing Chaoyang Hospital, Capital Medical University

ncuskouyangtao@163.com+86 10 8523 1086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026